Company / R&D per Share
CONMED Corporation R&D per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D per Share
$1.77
FY2025
5-year range
$1.37 / $1.81
FY2021-FY2025
Trend
-2.2%
vs FY2024
Sector context
#53 of 108
Health Care
What the data says
At $1.77, CONMED Corporation's r&d per share ranks #53 of 108 in the Health Care sector. R&D per Share has fluctuated over the past 10 years, ranging from $0.98 in FY2017 to $1.81 in FY2024.
Based on SEC 10-K filings.
1.77 in FY2025 with a 5-year CAGR of +3.9%.
Improved from $1.63 to $1.77 over the past 2 years.
Health Care sector context is included.
R&D per Share over time
Growth rates
- 3-Year CAGR
- +8.8%
- 5-Year CAGR
- +3.9%
- 10-Year CAGR
- -
Sector benchmark
#53 of 108 in Health CareTop 49% of 108This company $1.77 Sector average $2.07
▼
-14.4% below sector average
Key checks
Key Insights
- In FY2025, r&d per share decreased 2.2% year-over-year.
- Ranks #53 out of 108 companies in the Health Care sector.
- Peak r&d per share was recorded in FY2024.
- Lowest r&d per share in the period was in FY2017.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.77 | -2.2% |
| FY2024 | $1.81 | +11.0% |
| FY2023 | $1.63 | +18.9% |
| FY2022 | $1.37 | -10.9% |
| FY2021 | $1.54 | +5.5% |
| FY2020 | $1.46 | +27.3% |
| FY2019 | $1.15 | -0.6% |
| FY2018 | $1.15 | +17.1% |
| FY2017 | $0.98 | -1.6% |
| FY2016 | $1.00 | +2.5% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026